Published in J Magn Reson Imaging on April 15, 1993
Necrosis avidity: a newly discovered feature of hypericin and its preclinical applications in necrosis imaging. Theranostics (2013) 0.83
Coping with stigma: the experiences of Chinese patients living with lung cancer. Springerplus (2016) 0.75
Liposome-encapsulated superoxide dismutase mimetic: theranostic potential of an MR detectable and neuroprotective agent. Contrast Media Mol Imaging (2014) 0.75
Nanotechnology Applications for Diffuse Intrinsic Pontine Glioma. Curr Neuropharmacol (2016) 0.75
100-kDa polypeptides in peripheral clathrin-coated vesicles are required for receptor-mediated endocytosis. Proc Natl Acad Sci U S A (1989) 1.94
Proton-induced fusion of oleic acid-phosphatidylethanolamine liposomes. Biochemistry (1985) 1.88
Intracellular fate of Mycobacterium avium: use of dual-label spectrofluorometry to investigate the influence of bacterial viability and opsonization on phagosomal pH and phagosome-lysosome interaction. Infect Immun (1996) 1.75
Endocytosis of liposomes and intracellular fate of encapsulated molecules: encounter with a low pH compartment after internalization in coated vesicles. Cell (1983) 1.73
Candidacidal activity of salivary histatins. Identification of a histatin 5-binding protein on Candida albicans. J Biol Chem (1998) 1.69
Interaction of DNA with a porphyrin ligand: evidence for intercalation. Nucleic Acids Res (1979) 1.56
Rapid nuclear accumulation of injected oligodeoxyribonucleotides. New Biol (1990) 1.45
Liposome-mediated delivery of deoxyribonucleic acid to cells: enhanced efficiency of delivery related to lipid composition and incubation conditions. Biochemistry (1981) 1.39
Successful treatment with aerosolized pentamidine of Pneumocystis carinii pneumonia in rats. Antimicrob Agents Chemother (1987) 1.35
Formulation and efficacy of liposome-encapsulated antibiotics for therapy of intracellular Mycobacterium avium infection. Antimicrob Agents Chemother (1995) 1.23
Induction of DNA damage by porphyrin photosensitizers. Cancer Res (1981) 1.20
Selective enhancement of pentamidine uptake in the lung by aerosolization and delivery in liposomes. Am Rev Respir Dis (1987) 1.17
Selective tumor uptake of a boronated porphyrin in an animal model of cerebral glioma. Proc Natl Acad Sci U S A (1992) 1.17
Intercalative and nonintercalative binding of large cationic porphyrin ligands to calf thymus DNA. Nucleic Acids Res (1983) 1.17
DNA strand scission activity of metalloporphyrins. Biochem Biophys Res Commun (1982) 1.17
pH-sensitive liposomes mediate cytoplasmic delivery of encapsulated macromolecules. FEBS Lett (1985) 1.16
Novel taxol formulations: preparation and characterization of taxol-containing liposomes. Pharm Res (1994) 1.15
Selective tumor kill of cerebral glioma by photodynamic therapy using a boronated porphyrin photosensitizer. Proc Natl Acad Sci U S A (1995) 1.13
Liposome-mediated therapy of intracranial brain tumors in a rat model. Pharm Res (1997) 1.08
Binding of meso-tetra (4-N-methylpyridyl) porphine to DNA. Nucleic Acids Res (1980) 1.07
Antitumor effect of taxol-containing liposomes in a taxol-resistant murine tumor model. Cancer Res (1993) 1.00
Circular dichroism spectroscopy of a cationic porphyrin bound to DNA. Biochem Biophys Res Commun (1982) 0.97
Paclitaxel-liposomes for intracavitary therapy of intraperitoneal P388 leukemia. Cancer Lett (1996) 0.96
Liposomes as carriers for intracellular delivery of nucleic acids. Methods Enzymol (1983) 0.95
Metabolic imaging of rat brain during pharmacologically-induced tinnitus. Neuroimage (2008) 0.94
Taxol-lipid interactions: taxol-dependent effects on the physical properties of model membranes. Biochemistry (1994) 0.94
Pharmaceutical and physical properties of paclitaxel (Taxol) complexes with cyclodextrins. J Pharm Sci (1995) 0.94
Reversed-phase high-performance liquid chromatographic determination of taxol in mouse plasma. J Chromatogr B Biomed Appl (1994) 0.93
Small angle light scattering of bioparticles. 2. Cells and cellular organelles. Exp Cell Res (1970) 0.93
Relation between cholinesterase inhibitor and Pisa syndrome. Lancet (2000) 0.93
Cellular retention of liposome-delivered anionic compounds modulated by a probenecid-sensitive anion transporter. Pharm Res (1997) 0.92
Influence of cationic lipids on the stability and membrane properties of paclitaxel-containing liposomes. J Pharm Sci (2001) 0.90
Liposomes as formulation excipients for protein pharmaceuticals: a model protein study. Pharm Res (2000) 0.90
Differential regulation of NO availability from macrophages and endothelial cells by the garlic component S-allyl cysteine. Free Radic Biol Med (2001) 0.89
Functional magnetic resonance (fMR) imaging of a rat brain tumor model: implications for evaluation of tumor microvasculature and therapeutic response. Magn Reson Imaging (1999) 0.89
Solvent- and concentration-dependent molecular interactions of taxol (Paclitaxel). J Pharm Sci (1994) 0.89
Small-angle light scattering of bioparticles. 3. Vaccinia virus. Arch Biochem Biophys (1970) 0.88
Role of ligand in antibody-directed endocytosis of liposomes by human T-leukemia cells. Cancer Res (1989) 0.88
Specific inhibition of HIV-1 protease by boronated porphyrins. J Med Chem (1992) 0.88
A comparative study on the pharmacokinetics and biodistribution of boronated porphyrin (BOPP) and sulfhydryl boron hydride (BSH) in the RG2 rat glioma model. J Neurosurg (1995) 0.88
Small angle light scattering of bioparticles. I. Model systems. Exp Cell Res (1970) 0.87
In vitro determination of uptake, retention, distribution, biological efficacy, and toxicity of boronated compounds for neutron capture therapy: a comparison of porphyrins with sulfhydryl boron hydrides. Cancer Res (1990) 0.86
Radiation modifying effects of meso-tetraphenyl porphyrins. Res Commun Chem Pathol Pharmacol (1975) 0.84
Paclitaxel pharmacodynamics: application of a mechanism-based neutropenia model. Biopharm Drug Dispos (2001) 0.84
Very low-angle light scattering. A caharacterization method for high-molecular weight DNA. Biopolymers (1976) 0.84
Change of dopamine receptor mRNA expression in lymphocyte of schizophrenic patients. BMC Med Genet (2001) 0.83
Biological efficacy of boronated low-density lipoprotein for boron neutron capture therapy as measured in cell culture. Cancer Res (1991) 0.83
Boronated protoporphyrin (BOPP): localization in lysosomes of the human glioma cell line SF-767 with uptake modulated by lipoprotein levels. Int J Radiat Oncol Biol Phys (1999) 0.82
Phospholipid-cationic lipid interactions: influences on membrane and vesicle properties. Biochim Biophys Acta (2001) 0.81
Antitumor efficacy of taxane liposomes on a human ovarian tumor xenograft in nude athymic mice. J Pharm Sci (1995) 0.81
Structural characterization of partially thiolated poly(cytidylic acid). Biochemistry (1979) 0.81
Proton relaxation enhancement by manganese(III)TPPS4 in a model tumor system. Magn Reson Imaging (1987) 0.81
Role of divalent ion complex formation in pyran--inhibition of nucleic acid biosynthesis. J Natl Cancer Inst (1976) 0.81
Cutaneous photosensitizing and immunosuppressive effects of a series of tumor localizing porphyrins. Photochem Photobiol (1991) 0.81
A comparative study of manganese meso-sulfonatophenyl porphyrins: contrast-enhancing agents for tumors. Magn Reson Imaging (1990) 0.80
Inhibition of DNA dependent RNA synthesis by porphyrin photosensitizers. Biochem Biophys Res Commun (1980) 0.80
Coagulation and biochemical effects of balanced salt-based high molecular weight vs saline-based low molecular weight hydroxyethyl starch solutions during the anhepatic period of liver transplantation. Anaesthesia (2008) 0.80
Small animal magnetic resonance imaging: a means of studying the development of structural pathologies in the rat brain. Alcohol Clin Exp Res (1993) 0.80
DNA intercalation and photosensitization by cationic meso substituted porphyrins. Nucleic Acids Res (1992) 0.80
Small animal MRI at 0.35 Tesla: growth and morphology of intra-organ murine tumors. Magn Reson Imaging (1990) 0.79
Hematoporphyrin-sensitized photodynamic inactivation of viral RNA-dependent DNA polymerase. Res Commun Chem Pathol Pharmacol (1977) 0.79
Modulation of human ovarian tumor cell sensitivity to N-(phosphonacetyl)-L-aspartate (PALA) by liposome drug carriers. Pharm Res (1993) 0.79
Effects of risperidone on information processing and attention in first-episode schizophrenia. Schizophr Res (2002) 0.79
Ribonucleotide reductase activity in cell-free extracts of Yaba poxvirus tumor and normal monkey tissues. Cancer Res (1969) 0.78
Physicochemical, pharmacokinetic and pharmacodynamic evaluation of liposomal tacrolimus (FK 506) in rats. Pharm Res (1995) 0.78
DNA strand scission by iron complexes of meso-tetra(N-methylpyridyl)porphines. Chem Biol Interact (1988) 0.78
Photophysics and intracellular distribution of a boronated porphyrin phototherapeutic agent. Photochem Photobiol (1996) 0.78
On the origin of paramagnetic inhomogeneity effects in whole blood. Magn Reson Med (1991) 0.77
Boron neutron capture therapy for undifferentiated thyroid carcinoma: preliminary results with the combined use of BPA and BOPP. Appl Radiat Isot (2004) 0.77
Enhancement of tissue delivery and receptor occupancy of methylprednisolone in rats by a liposomal formulation. Pharm Res (1993) 0.77
Salicylic acid induces changes in the physical properties of model and native kidney membranes. J Pharm Sci (1997) 0.77
Toxicology of a boronated porphyrin in dogs. Photochem Photobiol (1999) 0.77
The line shapes of the water proton resonances of red blood cells containing carbonyl hemoglobin, deoxyhemoglobin, and methemoglobin: implications for the interpretation of proton MRI at fields of 1.5 T and below. Magn Reson Imaging (1990) 0.76
Mitochondria are the functional intracellular target for a photosensitizing boronated porphyrin. Biochim Biophys Acta (1996) 0.76
Phase I and pharmacokinetic study of photodynamic therapy for high-grade gliomas using a novel boronated porphyrin. J Clin Oncol (2001) 0.76
RNA synthesis in nuclei isolated from normal and Friend virus-infected mouse spleen. Cancer Res (1970) 0.76
Plasma pharmacokinetics and tissue biodistribution of boron following administration of a boronated porphyrin in dogs. J Pharm Sci (2000) 0.76
Biopharmaceutics of boronated radiosensitizers: liposomal formulation of MnBOPP (manganese chelate of 2,4-(alpha, beta-dihydroxyethyl) deuterioporphyrin IX) and comparative toxicity in mice. J Pharm Sci (1999) 0.76
A microcomputer-based algorithm for digitized image simplification and information extraction. Anal Quant Cytol Histol (1988) 0.75
Photosensitized formation of 8-hydroxy-2'-deoxyguanosine and DNA strand breakage by a cationic meso-substituted porphyrin. Photochem Photobiol (1994) 0.75
Magnetic resonance imaging (MRI) and pathophysiology of the rat kidney in streptozotocin-induced diabetes. Magn Reson Imaging (1991) 0.75
Temporal changes in chromatin isolated from Friend virus-infected mouse spleens. Cancer Biochem Biophys (1976) 0.75
A microcomputer based system for three-dimensional reconstructions from tomographic or histologic sections. Anal Quant Cytol Histol (1991) 0.75
Cellular structure as revealed by visible light scattering: studies on suspensions of red blood cell ghosts. Appl Opt (1976) 0.75
Magnetic resonance imaging and histopathology of hydronephrosis in the rat. Magn Reson Imaging (1991) 0.75
Distribution of a boronated porphyrin in murine tumors. Basic Life Sci (1989) 0.75
Isointense model for the evaluation of tumor-specific MRI contrast agents. Magn Reson Imaging (1988) 0.75
Divalent cation binding specificities and microsphere formation of pyran copolymer and related polycarboxylates. Arch Biochem Biophys (1977) 0.75
Boronated porphyrins in NCT: results with a new potent tumor localizer. Strahlenther Onkol (1989) 0.75
DNA interactive porphyrins: metalloporphyrin derivatives. Prog Clin Biol Res (1985) 0.75
Recent developments in neutron capture therapy. Strahlenther Onkol (1989) 0.75